Typhoid Vi Polysaccharide Vaccine Industry Insights 2025 – Market Forecast for Executives and Planners
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Typhoid Vi Polysaccharide Vaccine Market Size Changed, over the years?
The market size for the typhoid vi polysaccharide vaccine has seen a swift expansion in the past few years. Its growth is projected to accelerate from $5.78 billion in 2024 to $6.77 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 17.1%. Various factors driving the growth during the historic period include disease prevalence, global health initiatives, traveler vaccinations, governmental vaccination drives, as well as the effectiveness and safety of the vaccine.
How Much Will the Typhoid Vi Polysaccharide Vaccine Market Be Worth in 2029?
Expectations are high for the typhoid vi polysaccharide vaccine market to experience significant growth in the coming years, with projections estimating that it will reach $13.36 billion by 2029, growing at a compound annual growth rate (CAGR) of 18.5%. The predicted growth during the forecast period can be attributed to factors such as increased immunization initiatives, a growing focus on global health policies, epidemiological monitoring, a rise in demand within the field of travel medicine, as well as environmental and societal factors. Looking ahead, R&D investments, regulatory backing, epidemiological research, and public health awareness are key trends expected to shape the forecast period.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8313&type=smp
Which is the Largest Company in the Typhoid Vi Polysaccharide Vaccine Market?
Major companies operating in the typhoid vi polysaccharide vaccine market are Sanofi S.A., GlaxoSmithKline PLC, Merck & Co. Inc., Pfizer Inc., Johnson & Johnson Private Limited, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Emergent Biosolutions Inc., PT Bio Farma, Bharat Biotech International Limited, Teva Pharmaceutical Industries Ltd., Novartis AG, Bio-Med Pvt. Ltd., LG Chem, SK Chemicals Co. Ltd., Crucell Switzerland AG, Hualan Biological Engineering Inc., Indian Immunologicals Limited
What Are the Main Market Drivers in the Typhoid Vi Polysaccharide Vaccine Industry?
The escalating occurrence of typhoid is anticipated to fuel the expansion of the typhoid VI polysaccharide vaccine market. Typhoid, a potentially fatal disease, is brought on by the bacteria Salmonella typhi and is typically spread via infected beverages and food. The vaccine for Typhoid VI polysaccharide is utilized to protect both adults and children 2 years and over from typhoid fever, induced by Salmonella enterica serovar Typhi, S. Typhi. The UK Health Security Agency, a government establishment from the UK, shared data in August 2024 that proved a surge in the confirmed symptomatic cases of enteric fever in England, Wales, and Northern Ireland from 2021 to 2022. The figures showed that S. Typhi cases escalated from 108 to 313, S. Paratyphi A from 31 to 135, and S. Paratyphi B from 13 to 18 cases, respectively. As a result, the rising typhoid prevalence continues to drive the growth of the typhoid Vi polysaccharide vaccine market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=8313&type=smp
How Is the Typhoid Vi Polysaccharide Vaccine Market Segments Structured?
The typhoid vi polysaccharide vaccine market covered in this report is segmented –
1) By Type: Child, Adult
2) By Route Of Administration: Oral, Parenteral
3) By Application: Government Institution, Private Sector, Other Applications
Subsegments:
1) By Child: Pediatric Formulations, Age-Specific Dosages
2) By Adult: Standard Adult Formulations, High-Risk Population Formulations
What Strategic Trends Are Transforming the Typhoid Vi Polysaccharide Vaccine Market?
Key alliances are an emerging trend within the typhoid Vi polysaccharide vaccine market. Major players in this market are establishing partnerships that amplify their influence and solidify their standing in the market. For instance, in July 2022, the South Korea-based organization, The International Vaccine Institute, which focuses on infectious diseases of global significance like cholera, typhoid, shigella, and salmonella, formed a collaboration with Moderna, a biopharmaceutical firm based in the US. This collaboration resulted in the creation of the world’s first reasonably priced oral cholera vaccine and a new-generation typhoid conjugate vaccine.
Access The Full Report Here:
Which Global Regions Offer the Highest Growth in the Typhoid Vi Polysaccharide Vaccine Market?
Asia-Pacific was the largest region in the typhoid Vi polysaccharide vaccine market share in 2024. The regions covered in the typhoid vi polysaccharide vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8313
This Report Delivers Insight On:
1. How big is the typhoid vi polysaccharide vaccine market, and how is it changing globally?
2. Who are the major companies in the typhoid vi polysaccharide vaccine market, and how are they performing?
3. What are the key opportunities and risks in the typhoid vi polysaccharide vaccine market right now?
4. Which products or customer segments are growing the most in the typhoid vi polysaccharide vaccine market?
5. What factors are helping or slowing down the growth of the typhoid vi polysaccharide vaccine market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
